Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D02MGJ
|
|||
| Drug Name |
Benzoxazinone derivative 2
|
|||
| Synonyms |
PMID29171765-Compound-Figure3
Click to Show/Hide
|
|||
| Company |
UNIVERSITEIT ANTWERPESIXERA PHARMA AUNIVERSITE PIERRE ET MARIE CURIE (PARIS 6QUEENSLAND UNIVERSITY OF TECHNOLOGY HARRIS, Jonathan Malcolm DE VEER, Simon John SWEDBERG, Joakim Erik
|
|||
| Structure |
 |
Download2D MOL |
||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Kallikrein-4 (KLK4) | Target Info | Inhibitor | [1] |
| Kallikrein-related peptidase (KLK) | Target Info | Inhibitor | [1] | |
| Target's Patent Info | Kallikrein-4 (KLK4) | Target's Patent Info | [1] | |
| Kallikrein-related peptidase (KLK) | Target's Patent Info | [1] | ||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Serine protease inhibitors to treat inflammation: a patent review (2011-2016).Expert Opin Ther Pat. 2018 Feb;28(2):93-110. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.